| The demands that stakeholders are placing on drug safety units can only be met through a structured approach to radically improve effectiveness and efficiency. Periodic safety update reports (PSURs) are effective stimuli for proactive pharmacovigilance, but they need to be produced at an even rate and with guaranteed consistency in both format and content. As the volumes of safety data continue to increase, firms that accept the status quo will restrict the ability to deliver accurate and timely safety data to patients, physicians and agencies. |